Xellia Pharmaceuticals AS is a global leader in fermentation-based non-beta-lactam anti-infectives. The company specializes in the production and supply of active pharmaceutical ingredients (APIs) as well as finished dosage forms (FDFs). With over 120 years of experience in the pharmaceutical industry, Xellia has established itself as a significant player, supplying more than 500 pharmaceutical companies in 80 countries.
The company is regarded by the World Health Organization and the EU as a reliable supplier of essential medicines. Xellia has production facilities in Denmark, Hungary and China, and is known as a unique European manufacturer of several specific products. This makes them an important partner in the global pharmaceutical industry.